Global Aptamer Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aptamer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 DNA-Based Aptamers
1.2.3 RNA-Based Aptamers
1.3 Market by Application
1.3.1 Global Aptamer Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Research and Development
1.3.3 Drug Discovery
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Aptamer Market Size (2017-2028)
2.2 Aptamer Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Aptamer Market Size by Region (2017-2022)
2.4 Global Aptamer Market Size Forecast by Region (2023-2028)
2.5 Global Top Aptamer Countries Ranking by Market Size
3 Aptamer Competitive by Company
3.1 Global Aptamer Revenue by Players
3.1.1 Global Aptamer Revenue by Players (2017-2022)
3.1.2 Global Aptamer Market Share by Players (2017-2022)
3.2 Global Aptamer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Aptamer Revenue
3.4 Global Aptamer Market Concentration Ratio
3.4.1 Global Aptamer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aptamer Revenue in 2021
3.5 Global Aptamer Key Players Head office and Area Served
3.6 Key Players Aptamer Product Solution and Service
3.7 Date of Enter into Aptamer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Aptamer Breakdown Data by Type
4.1 Global Aptamer Historic Revenue by Type (2017-2022)
4.2 Global Aptamer Forecasted Revenue by Type (2023-2028)
5 Global Aptamer Breakdown Data by Application
5.1 Global Aptamer Historic Market Size by Application (2017-2022)
5.2 Global Aptamer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Aptamer Revenue by Company (2020-2022)
6.2 North America Aptamer Revenue by Type (2017-2028)
6.3 North America Aptamer Revenue by Application (2017-2028)
6.4 North America Aptamer Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Aptamer Revenue by Company (2020-2022)
7.2 Europe Aptamer Revenue by Type (2017-2028)
7.3 Europe Aptamer Revenue by Application (2017-2028)
7.4 Europe Aptamer Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Aptamer Revenue by Company (2020-2022)
8.2 Asia Pacific Aptamer Revenue by Type (2017-2028)
8.3 Asia Pacific Aptamer Revenue by Application (2017-2028)
8.4 Asia Pacific Aptamer Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Aptamer Revenue by Company (2020-2022)
9.2 Latin America Aptamer Revenue by Type (2017-2028)
9.3 Latin America Aptamer Revenue by Application (2017-2028)
9.4 Latin America Aptamer Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Aptamer Revenue by Company (2020-2022)
10.2 Middle East and Africa Aptamer Revenue by Type (2017-2028)
10.3 Middle East and Africa Aptamer Revenue by Application (2017-2028)
10.4 Middle East and Africa Aptamer Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 TriLink BioTechnologies
11.1.1 TriLink BioTechnologies Company Details
11.1.2 TriLink BioTechnologies Business Overview
11.1.3 TriLink BioTechnologies Aptamer Products and Services
11.1.4 TriLink BioTechnologies Aptamer Revenue in Aptamer Business (2017-2022)
11.1.5 TriLink BioTechnologies Aptamer SWOT Analysis
11.1.6 TriLink BioTechnologies Recent Developments
11.2 AptaBharat
11.2.1 AptaBharat Company Details
11.2.2 AptaBharat Business Overview
11.2.3 AptaBharat Aptamer Products and Services
11.2.4 AptaBharat Aptamer Revenue in Aptamer Business (2017-2022)
11.2.5 AptaBharat Aptamer SWOT Analysis
11.2.6 AptaBharat Recent Developments
11.3 SomaLogic
11.3.1 SomaLogic Company Details
11.3.2 SomaLogic Business Overview
11.3.3 SomaLogic Aptamer Products and Services
11.3.4 SomaLogic Aptamer Revenue in Aptamer Business (2017-2022)
11.3.5 SomaLogic Aptamer SWOT Analysis
11.3.6 SomaLogic Recent Developments
11.4 AM Biotechnologies
11.4.1 AM Biotechnologies Company Details
11.4.2 AM Biotechnologies Business Overview
11.4.3 AM Biotechnologies Aptamer Products and Services
11.4.4 AM Biotechnologies Aptamer Revenue in Aptamer Business (2017-2022)
11.4.5 AM Biotechnologies Aptamer SWOT Analysis
11.4.6 AM Biotechnologies Recent Developments
11.5 Aptamer Sciences
11.5.1 Aptamer Sciences Company Details
11.5.2 Aptamer Sciences Business Overview
11.5.3 Aptamer Sciences Aptamer Products and Services
11.5.4 Aptamer Sciences Aptamer Revenue in Aptamer Business (2017-2022)
11.5.5 Aptamer Sciences Aptamer SWOT Analysis
11.5.6 Aptamer Sciences Recent Developments
11.6 Base Pair Biotechnologies
11.6.1 Base Pair Biotechnologies Company Details
11.6.2 Base Pair Biotechnologies Business Overview
11.6.3 Base Pair Biotechnologies Aptamer Products and Services
11.6.4 Base Pair Biotechnologies Aptamer Revenue in Aptamer Business (2017-2022)
11.6.5 Base Pair Biotechnologies Aptamer SWOT Analysis
11.6.6 Base Pair Biotechnologies Recent Developments
11.7 Aptamer Group
11.7.1 Aptamer Group Company Details
11.7.2 Aptamer Group Business Overview
11.7.3 Aptamer Group Aptamer Products and Services
11.7.4 Aptamer Group Aptamer Revenue in Aptamer Business (2017-2022)
11.7.5 Aptamer Group Aptamer SWOT Analysis
11.7.6 Aptamer Group Recent Developments
11.8 Aptagen
11.8.1 Aptagen Company Details
11.8.2 Aptagen Business Overview
11.8.3 Aptagen Aptamer Products and Services
11.8.4 Aptagen Aptamer Revenue in Aptamer Business (2017-2022)
11.8.5 Aptagen Aptamer SWOT Analysis
11.8.6 Aptagen Recent Developments
11.9 Aptus Biotech
11.9.1 Aptus Biotech Company Details
11.9.2 Aptus Biotech Business Overview
11.9.3 Aptus Biotech Aptamer Products and Services
11.9.4 Aptus Biotech Aptamer Revenue in Aptamer Business (2017-2022)
11.9.5 Aptus Biotech Aptamer SWOT Analysis
11.9.6 Aptus Biotech Recent Developments
11.10 NeoVentures Biotechnology
11.10.1 NeoVentures Biotechnology Company Details
11.10.2 NeoVentures Biotechnology Business Overview
11.10.3 NeoVentures Biotechnology Aptamer Products and Services
11.10.4 NeoVentures Biotechnology Aptamer Revenue in Aptamer Business (2017-2022)
11.10.5 NeoVentures Biotechnology Aptamer SWOT Analysis
11.10.6 NeoVentures Biotechnology Recent Developments
11.11 Ray Biotech
11.11.1 Ray Biotech Company Details
11.11.2 Ray Biotech Business Overview
11.11.3 Ray Biotech Aptamer Products and Services
11.11.4 Ray Biotech Aptamer Revenue in Aptamer Business (2017-2022)
11.11.5 Ray Biotech Recent Developments
11.12 Vivonics
11.12.1 Vivonics Company Details
11.12.2 Vivonics Business Overview
11.12.3 Vivonics Aptamer Products and Services
11.12.4 Vivonics Aptamer Revenue in Aptamer Business (2017-2022)
11.12.5 Vivonics Recent Developments
12 Aptamer Market Dynamics
12.1 Aptamer Market Trends
12.2 Aptamer Market Drivers
12.3 Aptamer Market Challenges
12.4 Aptamer Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Aptamer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of DNA-Based Aptamers
Table 3. Key Players of RNA-Based Aptamers
Table 4. Global Aptamer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Aptamer Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Aptamer Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Aptamer Revenue Market Share by Region (2017-2022)
Table 8. Global Aptamer Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Aptamer Market Share by Players (2017-2022)
Table 10. Global Top Aptamer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aptamer as of 2021)
Table 11. Ranking of Global Top Aptamer Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Aptamer Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Aptamer Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Aptamer Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Aptamer Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Aptamer Revenue Market Share by Type (2017-2022)
Table 19. Global Aptamer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Aptamer Revenue Market Share by Type (2023-2028)
Table 21. Global Aptamer Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Aptamer Revenue Market Share by Application (2017-2022)
Table 23. Global Aptamer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Aptamer Revenue Market Share by Application (2023-2028)
Table 25. North America Aptamer Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Aptamer Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Aptamer Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Aptamer Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Aptamer Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Aptamer Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Aptamer Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Aptamer Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Aptamer Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Aptamer Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Aptamer Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Aptamer Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Aptamer Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Aptamer Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Aptamer Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Aptamer Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Aptamer Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Aptamer Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Aptamer Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Aptamer Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Aptamer Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Aptamer Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Aptamer Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Aptamer Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Aptamer Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Aptamer Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Aptamer Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Aptamer Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Aptamer Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Aptamer Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Aptamer Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Aptamer Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Aptamer Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Aptamer Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Aptamer Revenue by Country (2023-2028) & (US$ Million)
Table 60. TriLink BioTechnologies Company Details
Table 61. TriLink BioTechnologies Business Overview
Table 62. TriLink BioTechnologies Aptamer Product and Services
Table 63. TriLink BioTechnologies Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 64. TriLink BioTechnologies Aptamer SWOT Analysis
Table 65. TriLink BioTechnologies Recent Developments
Table 66. AptaBharat Company Details
Table 67. AptaBharat Business Overview
Table 68. AptaBharat Aptamer Product and Services
Table 69. AptaBharat Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 70. AptaBharat Aptamer SWOT Analysis
Table 71. AptaBharat Recent Developments
Table 72. SomaLogic Company Details
Table 73. SomaLogic Business Overview
Table 74. SomaLogic Aptamer Product and Services
Table 75. SomaLogic Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 76. SomaLogic Aptamer SWOT Analysis
Table 77. SomaLogic Recent Developments
Table 78. AM Biotechnologies Company Details
Table 79. AM Biotechnologies Business Overview
Table 80. AM Biotechnologies Aptamer Product and Services
Table 81. AM Biotechnologies Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 82. AM Biotechnologies Aptamer SWOT Analysis
Table 83. AM Biotechnologies Recent Developments
Table 84. Aptamer Sciences Company Details
Table 85. Aptamer Sciences Business Overview
Table 86. Aptamer Sciences Aptamer Product and Services
Table 87. Aptamer Sciences Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 88. Aptamer Sciences Aptamer SWOT Analysis
Table 89. Aptamer Sciences Recent Developments
Table 90. Base Pair Biotechnologies Company Details
Table 91. Base Pair Biotechnologies Business Overview
Table 92. Base Pair Biotechnologies Aptamer Product and Services
Table 93. Base Pair Biotechnologies Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 94. Base Pair Biotechnologies Aptamer SWOT Analysis
Table 95. Base Pair Biotechnologies Recent Developments
Table 96. Aptamer Group Company Details
Table 97. Aptamer Group Business Overview
Table 98. Aptamer Group Aptamer Product and Services
Table 99. Aptamer Group Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 100. Aptamer Group Aptamer SWOT Analysis
Table 101. Aptamer Group Recent Developments
Table 102. Aptagen Company Details
Table 103. Aptagen Business Overview
Table 104. Aptagen Aptamer Product and Services
Table 105. Aptagen Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 106. Aptagen Aptamer SWOT Analysis
Table 107. Aptagen Recent Developments
Table 108. Aptus Biotech Company Details
Table 109. Aptus Biotech Business Overview
Table 110. Aptus Biotech Aptamer Product and Services
Table 111. Aptus Biotech Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 112. Aptus Biotech Aptamer SWOT Analysis
Table 113. Aptus Biotech Recent Developments
Table 114. NeoVentures Biotechnology Company Details
Table 115. NeoVentures Biotechnology Business Overview
Table 116. NeoVentures Biotechnology Aptamer Product and Services
Table 117. NeoVentures Biotechnology Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 118. NeoVentures Biotechnology Aptamer SWOT Analysis
Table 119. NeoVentures Biotechnology Recent Developments
Table 120. Ray Biotech Company Details
Table 121. Ray Biotech Business Overview
Table 122. Ray Biotech Aptamer Product and Services
Table 123. Ray Biotech Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 124. Ray Biotech Recent Developments
Table 125. Vivonics Company Details
Table 126. Vivonics Business Overview
Table 127. Vivonics Aptamer Product and Services
Table 128. Vivonics Aptamer Revenue in Aptamer Business (2017-2022) & (US$ Million)
Table 129. Vivonics Recent Developments
Table 130. Aptamer Market Trends
Table 131. Aptamer Market Drivers
Table 132. Aptamer Market Challenges
Table 133. Aptamer Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Aptamer Sales Market Share by Type: 2021 VS 2028
Figure 2. DNA-Based Aptamers Features
Figure 3. RNA-Based Aptamers Features
Figure 4. Global Aptamer Sales Market Share by Application: 2021 VS 2028
Figure 5. Research and Development Case Studies
Figure 6. Drug Discovery Case Studies
Figure 7. Aptamer Report Years Considered
Figure 8. Global Aptamer Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Aptamer Market Size 2017-2028 (US$ Million)
Figure 10. Global Aptamer Market Size Market Share by Region: 2021 VS 2028
Figure 11. Global Aptamer Revenue Market Share by Region in 2017 VS 2022
Figure 12. Global Top 10 Aptamer Countries Ranking by Market Size (US$ Million) in 2021
Figure 13. Global Aptamer Market Share by Players in 2021
Figure 14. Global Top Aptamer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aptamer as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Aptamer Revenue in 2021
Figure 16. North America Aptamer Revenue Market Share by Company in 2021
Figure 17. North America Aptamer Revenue Market Share by Type (2017-2028)
Figure 18. North America Aptamer Revenue Market Share by Application (2017-2028)
Figure 19. North America Aptamer Revenue Share by Country (2017-2028)
Figure 20. U.S. Aptamer Revenue (2017-2028) & (US$ Million)
Figure 21. Canada Aptamer Revenue (2017-2028) & (US$ Million)
Figure 22. Europe Aptamer Revenue Market Share by Company in 2021
Figure 23. Europe Aptamer Revenue Market Share by Type (2017-2028)
Figure 24. Europe Aptamer Revenue Market Share by Application (2017-2028)
Figure 25. Europe Aptamer Revenue Share by Country (2017-2028)
Figure 26. Germany Aptamer Revenue (2017-2028) & (US$ Million)
Figure 27. France Aptamer Revenue (2017-2028) & (US$ Million)
Figure 28. U.K. Aptamer Revenue (2017-2028) & (US$ Million)
Figure 29. Italy Aptamer Revenue (2017-2028) & (US$ Million)
Figure 30. Russia Aptamer Revenue (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Aptamer Revenue Market Share by Company in 2021
Figure 32. Asia Pacific Aptamer Revenue Market Share by Type (2017-2028)
Figure 33. Asia Pacific Aptamer Revenue Market Share by Application (2017-2028)
Figure 34. Asia Pacific Aptamer Revenue Share by Region (2017-2028)
Figure 35. China Aptamer Revenue (2017-2028) & (US$ Million)
Figure 36. Japan Aptamer Revenue (2017-2028) & (US$ Million)
Figure 37. South Korea Aptamer Revenue (2017-2028) & (US$ Million)
Figure 38. India Aptamer Revenue (2017-2028) & (US$ Million)
Figure 39. Australia Aptamer Revenue (2017-2028) & (US$ Million)
Figure 40. Taiwan Aptamer Revenue (2017-2028) & (US$ Million)
Figure 41. Indonesia Aptamer Revenue (2017-2028) & (US$ Million)
Figure 42. Thailand Aptamer Revenue (2017-2028) & (US$ Million)
Figure 43. Malaysia Aptamer Revenue (2017-2028) & (US$ Million)
Figure 44. Philippines Aptamer Revenue (2017-2028) & (US$ Million)
Figure 45. Vietnam Aptamer Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Aptamer Revenue Market Share by Company in 2021
Figure 47. Latin America Aptamer Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Aptamer Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Aptamer Revenue Share by Country (2017-2028)
Figure 50. Mexico Aptamer Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Aptamer Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Aptamer Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Aptamer Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Aptamer Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Aptamer Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Aptamer Revenue Share by Country (2017-2028)
Figure 57. Turkey Aptamer Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Aptamer Revenue (2017-2028) & (US$ Million)
Figure 59. U.A.E Aptamer Revenue (2017-2028) & (US$ Million)
Figure 60. TriLink BioTechnologies Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 61. AptaBharat Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 62. SomaLogic Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 63. AM Biotechnologies Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 64. Aptamer Sciences Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 65. Base Pair Biotechnologies Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 66. Aptamer Group Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 67. Aptagen Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 68. Aptus Biotech Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 69. NeoVentures Biotechnology Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 70. Ray Biotech Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 71. Vivonics Revenue Growth Rate in Aptamer Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed